The most important financial indicators for the company Hipy Bio Srl - Unique Identification Number 36359839:
sales in 2023 was
131.481
euro, registering a net profit of
58.542
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Fabricarea sucurilor de fructe şi legume having the NACE code 1032.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 19.4%, from 110.457 euro in the year 2022, to 131.481 euro in 2023.
The Net Profit decreased by -4.839 euro, from 63.574 euro in 2022, to 58.542 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Hipy Bio Srl - CUI 36359839
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
1.445
5.826
4.381
8.071
52.456
53.669
78.765
146.360
Current Assets
-
-
25.316
66.000
134.875
217.419
259.746
281.448
281.134
344.013
Inventories
-
-
18.114
16.798
27.281
25.601
18.322
15.273
14.774
62.711
Receivables
-
-
6.464
17.106
22.204
14.433
40.843
38.551
27.490
47.357
Cash
-
-
738
32.096
20.923
19.337
14.520
5.258
4.662
233.946
Shareholders Funds
-
-
508
12.025
36.379
79.384
159.773
219.441
283.696
341.378
Social Capital
-
-
45
44
43
42
41
40
41
40
Debts
-
-
26.414
59.947
102.877
146.179
152.470
115.746
81.457
120.788
Income in Advance
-
-
0
0
0
0
0
0
0
28.207
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"1032 - 1032"
CAEN Financial Year
1032
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
344.013 euro in 2023 which includes Inventories of
62.711 euro, Receivables of
47.357 euro and cash availability of
233.946 euro.
The company's Equity was valued at
341.378 euro, while total Liabilities amounted to
120.788 euro.
Equity increased by 58.542 euro, from 283.696 euro in 2022, to 341.378 in 2023.
The Debt Ratio was 24.6% in the year 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Hipy Bio Srl